Irreversible electroporation: state of the art

The field of focal ablative therapy for the treatment of cancer is characterized by abundance of thermal ablative techniques that provide a minimally invasive treatment option in selected tumors. However, the unselective destruction inflicted by thermal ablation modalities can result in damage to vital structures in the vicinity of the tumor. Furthermore, the efficacy of thermal ablation intensity can be impaired due to thermal sink caused by large blood vessels in the proximity of the tumor. Irreversible electroporation (IRE) is a novel ablation modality based on the principle of electroporation or electropermeabilization, in which electric pulses are used to create nanoscale defects in the cell membrane. In theory, IRE has the potential of overcoming the aforementioned limitations of thermal ablation techniques. This review provides a description of the principle of IRE, combined with an overview of in vivo research performed to date in the liver, pancreas, kidney, and prostate.

[1]  Boris Rubinsky,et al.  Tumor Ablation with Irreversible Electroporation , 2007, PloS one.

[2]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[3]  Samuel K. Park,et al.  Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. , 2013, Urology.

[4]  H. Itoh,et al.  Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope. , 1988, Biophysical journal.

[5]  G. Kazemier,et al.  Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study , 2014, European Radiology.

[6]  David W. Taggart,et al.  No surgical innovation without evaluation: the IDEAL recommendations , 2009, The Lancet.

[7]  Amita Sharma,et al.  Image-guided ablative therapies for lung cancer. , 2012, Radiologic clinics of North America.

[8]  H. Ahmed,et al.  INITIAL ASSESSMENT OF SAFETY AND CLINICAL FEASIBILITY OF IRREVERSIBLE ELECTROPORATION IN THE FOCAL TREATMENT OF PROSTATE CANCER , 2014, Prostate Cancer and Prostatic Disease.

[9]  Andrea Lodi,et al.  Design of an Irreversible Electroporation System for Clinical Use , 2007, Technology in cancer research & treatment.

[10]  Daniel M de Bruin,et al.  Thermal Energy during Irreversible Electroporation and the Influence of Different Ablation Parameters. , 2016, Journal of vascular and interventional radiology : JVIR.

[11]  J. Cadeddu,et al.  Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience. , 2015, Journal of vascular and interventional radiology : JVIR.

[12]  Jens Ricke,et al.  Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study , 2011, CardioVascular and Interventional Radiology.

[13]  Yoshiyuki Kobayashi,et al.  Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan , 2015, Japanese Journal of Radiology.

[14]  Vic Velanovich,et al.  Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Potential Improved Overall Survival , 2013, Annals of Surgical Oncology.

[15]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[16]  C. Bassi,et al.  Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study , 2015, Digestive Surgery.

[17]  E. Jung,et al.  Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. , 2015, Journal of vascular and interventional radiology : JVIR.

[18]  Yuman Fong,et al.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation. , 2012, Journal of the American College of Surgeons.

[19]  T. Reese,et al.  Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. , 1990, Biophysical journal.

[20]  Damijan Miklavčič,et al.  Electrochemotherapy: from the drawing board into medical practice , 2014, BioMedical Engineering OnLine.

[21]  J. Köllermann,et al.  First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial , 2016, CardioVascular and Interventional Radiology.

[22]  H. Itoh,et al.  Membrane conductance of an electroporated cell analyzed by submicrosecond imaging of transmembrane potential. , 1991, Biophysical journal.

[23]  V. Shelat,et al.  Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future. , 2015, World journal of gastrointestinal oncology.

[24]  Oxford Centre for Evidence-based Medicine Levels of Evidence (January 2001) , 2014 .

[25]  S. Kee,et al.  Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. , 2012, Journal of vascular and interventional radiology : JVIR.

[26]  Boris Rubinsky,et al.  Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer , 2010 .

[27]  Stuart K. Roberts,et al.  Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience and Review of Safety and Outcomes , 2013, Technology in Cancer Research and Treatment.

[28]  S. Chalikonda,et al.  Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. , 2015, Annals of surgery.

[29]  R. Lencioni,et al.  Hepatocellular carcinoma: new options for image-guided ablation , 2010, Journal of hepato-biliary-pancreatic sciences.

[30]  Thomas Wimmer,et al.  Planning Irreversible Electroporation in the Porcine Kidney: Are Numerical Simulations Reliable for Predicting Empiric Ablation Outcomes? , 2015, CardioVascular and Interventional Radiology.

[31]  B. Benway Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study: Pech M, Janitzky A, Wendler JJ, et al (Univ of Magdeburg, Germany) Cardiovasc Intervent Radiol 34:132-138, 2011§ , 2011 .

[32]  S. Solomon,et al.  Percutaneous ablation of peribiliary tumors with irreversible electroporation. , 2014, Journal of vascular and interventional radiology : JVIR.

[33]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[34]  John C. Bischof,et al.  A Review of Basic to Clinical Studies of Irreversible Electroporation Therapy , 2015, IEEE Transactions on Biomedical Engineering.

[35]  Suyashree Bhonsle,et al.  Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy , 2015, The Prostate.

[36]  Chad R. Tracy,et al.  Irreversible electroporation (IRE): a novel method for renal tissue ablation , 2011, BJU international.

[37]  Novel methods for renal tissue ablation , 2012, Current opinion in urology.

[38]  Boris Rubinsky,et al.  Irreversible Electroporation: A New Ablation Modality — Clinical Implications , 2007, Technology in cancer research & treatment.

[39]  G. Narayanan,et al.  Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. , 2012, Journal of vascular and interventional radiology : JVIR.

[40]  H. Rhim,et al.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.

[41]  Martin L. Yarmush,et al.  Nonthermal Irreversible Electroporation: Fundamentals, Applications, and Challenges , 2013, IEEE Transactions on Biomedical Engineering.

[42]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[43]  Robert C. G. Martin,et al.  Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures , 2013, Journal of surgical oncology.

[44]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[45]  T. Kawabe,et al.  Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations , 2006, Hepatology.

[46]  Inderbir S Gill,et al.  Contemporary management of small renal masses. , 2011, European urology.

[47]  Ton G van Leeuwen,et al.  Irreversible electroporation of the porcine kidney: Temperature development and distribution. , 2015, Urologic oncology.

[48]  Hessel Wijkstra,et al.  The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol , 2015, BMC Cancer.

[49]  Vic Velanovich,et al.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. , 2012, Journal of the American College of Surgeons.

[50]  Allard C van der Wal,et al.  Irreversible electroporation: Just another form of thermal therapy? , 2014, The Prostate.

[51]  K. Katsanos,et al.  Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.

[52]  J. J. de la Rosette,et al.  Thermal ablation in renal cell carcinoma management: a comprehensive review , 2014, Current opinion in urology.

[53]  G. Andriole Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer , 2013 .

[54]  Boris Rubinsky,et al.  In vivo imaging of irreversible electroporation by means of electrical impedance tomography , 2009, Physics in medicine and biology.

[55]  P. Scardino,et al.  What is still needed to make focal therapy an accepted segment of standard therapy? , 2014, Current opinion in urology.

[56]  M. Yeh,et al.  Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis. , 2015, Journal of vascular and interventional radiology : JVIR.

[57]  C. V. van Kuijk,et al.  Anaesthetic management during open and percutaneous irreversible electroporation. , 2014, British journal of anaesthesia.

[58]  Damijan Miklavčič,et al.  Electroporation-based technologies for medicine: principles, applications, and challenges. , 2014, Annual review of biomedical engineering.

[59]  Nathan Lawrentschuk,et al.  The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review , 2014, European urology.

[60]  Helen Kavnoudias,et al.  Investigation of the safety of irreversible electroporation in humans. , 2011, Journal of vascular and interventional radiology : JVIR.

[61]  C. D. Savci-Heijink,et al.  The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients , 2015, World Journal of Urology.